Village Farms International, Inc. (VFF) SEC Filings & Earnings Calls

Interim CFO appointment may indicate uncertainty in permanent succession.

“appointment of Hamid Shekarchi as Interim Chief Financial Officer” · word for word

CFO transition could disrupt financial operations during a period of growth and global expansion.

“during this pivotal time of growth and global expansion” · word for word

Dependence on international regulatory environment for cannabis exports; any adverse changes could impact revenue growth.

“International export sales are a significant growth driver; regulatory changes in Europe or other markets could affect demand.”

Execution risk related to Delta 2 expansion ramp-up to full production by mid-2027.

“Delta 2 expansion expected to ramp to full production capacity of 40 metric tonnes by mid-2027; any delays could impact revenue expectations.”

Canadian excise tax burden

“Excise duties of $14,909, or 39% of gross Canadian Branded sales, are the single largest cost.” · word for word

U.S. Cannabis regulatory risk

“U.S. Cannabis sales decreased by 16% due to unregulated hemp products and state regulation changes.”

Dependence on international markets

“International exports now 33% of revenue; subject to regulatory and geopolitical risks.”

Dilution from issuance of 7.5M new shares.

“7,500,000 common shares at US$2.00 per share.”

Cash flow used in operations ($11.8M) due to $15M income tax payment; potential liquidity pressure if tax payments recur.

“Cash flow used in operations was ($11.8) million, driven by the impact of US $15.0 million of Canadian income taxes paid in Q1 2026 related to tax obligations from the previous fiscal year.” · word for word

CFO succession planning introduces management transition risk.

“Began a succession planning process for Chief Financial Officer Steve Ruffini, who will remain an employee of the Company to help ensure a smooth transition of CFO responsibilities.” · word for word

Canadian excise tax burden

“For the three months ended March 31, 2026, the Company incurred excise duties of $15,903, or 40% of gross Canadian Branded sales.” · word for word

US cannabis regulatory uncertainty

“Sales for U.S. Cannabis decreased by $771, or 20%, due to lower direct-to-consumer sales resulting from the proliferation of unregulated hemp-derived products on the market and the continuing effect of changes in state regulations restricting sales.” · word for word

Negative operating cash flow

“Net cash flow used in operating activities ($16,763) for the three months ended March 31, 2026.”

CBD recriminalization in the U.S.

“The November 2025 Appropriations Act will effectively recriminalize CBD in the United States which could have a material adverse effect on our U.S. cannabis segment.” · word for word

High Canadian excise tax burden

“For the year ended December 31, 2025, the Company incurred excise duties of $59,950 (C$83,744), or 38% of gross branded sales.” · word for word

Share dilution from outstanding warrants and options

“As of March 6, 2026, 15,298,900 of the 2023 Common Warrants were still outstanding ... 6,159,411 Common Shares issuable upon exercise of outstanding options at a weighted-average exercise price of $3.47 per share and 2,106,376 of Restricted Stock Units were outstanding.” · word for word

U.S./Canadian tariffs and trade restrictions

“Our business may also be materially affected by potential U.S./Canadian tariffs and/or other trade restrictions.” · word for word

Inflation and supply chain cost pressure

“Inflation has affected and continues to affect supply chain and labor costs as well as purchasing decisions of consumers, amongst other items, which may impact demand for our products.” · word for word

Demand significantly outpaces current production capacity, creating temporary supply constraints.

“Demand for our products continues to significantly outpace our current production capacity, and temporary supply constraints... has created near-term variability in performance.” · word for word

U.S. cannabis segment sales declining and gross margin decreasing.

“U.S. Cannabis net sales were $3.4 million compared with $4.6 million; gross margin decreased to 60% from 70%.” · word for word

Produce segment sales down and generating losses.

“Produce sales from continuing operations of $4.9 million were down from $6.1 million; net loss from continuing operations was ($1.6 million).”

U.S. Cannabis segment (Balanced Health Botanicals) net sales declined to $3.3M from $3.9M; net loss widened.

“Net sales were $3.3 million compared with $3.9 million; Net loss was $0.4 million compared with a net loss of $0.2 million.”

U.S. Cannabis regulatory and competitive headwinds

“U.S. Cannabis net sales for the three months ended September 30, 2025 were $3,337 compared with $3,943 for the three months ended September 30, 2024. The decrease of $606, or 15%, was primarily due to lower direct-to-consumer sales resulting from the proliferation of unregulated hemp-derived products on the market and changes in state regulations restricting” · word for word

Canadian excise tax burden

“For the three months ended September 30, 2025, the Company incurred excise duties of $15,712 (C$21,647), or 37% of gross branded sales, compared with $17,674 (C$24,109), or 39% of gross branded sales, for the three months ended September 30, 2024.” · word for word